Results 71 to 80 of about 25,820 (298)
BMC Nephrology, 2019 BackgroundHyperphosphatemia is associated with vascular calcification and bone mineral disorders and is a major concern among patients with chronic kidney disease (CKD).
Hongran Moon +6 more
semanticscholar +1 more source
Alkaline phosphatases in the complex chronic kidney disease-mineral and bone disorders [PDF]
, 2018 Alkaline phosphatases (APs) remove the phosphate (dephosphorylation) needed in multiple metabolic processes (from many molecules such as proteins, nucleotides, or pyrophosphate). Therefore, APs are important for bone mineralization but paradoxically they
Aguilar, Armando +8 more
core +1 more source
Polymeric Anti‐Antibiotic Microparticles to Prevent Antibiotic Resistance Evolution
Small, Volume 21, Issue 21, May 26, 2025.This study introduces sevelamer (SEV) microparticles as a repurposed adjuvant therapy to combat antimicrobial resistance. SEV microparticles effectively capture vancomycin (VAN) and daptomycin (DAP), preventing these last‐resort antibiotics from driving resistance.
Roya Koshani +8 more
wiley +1 more source
The calcilytic agent NPS 2143 rectifies hypocalcemia in a mouse model with an activating calcium-sensing-receptor (CaSR) mutation:relevance to autosomal dominant hypocalcemia type 1 (ADH1) [PDF]
, 2015 Autosomal dominant hypocalcemia type 1 (ADH1) is caused by germline gain-of-function mutations of the calcium-sensing receptor (CaSR) and may lead to symptomatic hypocalcemia, inappropriately low serum parathyroid hormone (PTH) concentrations and ...
Allen M. Spiegel +44 more
core +1 more source
Small Science, EarlyView.The incorporation of perfluoroalkyl chains into porous NU‐1000 leads to superior performance in the removal of uremic toxins from samples of CKD patients for two main reasons: improved stability and enhanced removal efficiency of protein‐bound toxins.
Fátima Guerrero +4 more
wiley +1 more source
Polymyositis associated with dyspnoea and interstitial lung disease in a dog (Canis familiaris)
Veterinary Record Case Reports, EarlyView.Abstract A 5‐year‐old, female, spayed coonhound was evaluated for progressive dyspnoea, weakness and weight loss. The patient had increased inspiratory and expiratory respiratory effort and generalised skeletal muscle atrophy. Thoracic radiographs and computed tomography revealed interstitial lung disease. Magnetic resonance imaging revealed multifocal
Kaycee Daentl +2 more
wiley +1 more source
Effects of Use of Proton Pump Inhibitors with Calcium Acetate on Serum Phosphorus Levels in Hemodialysis Patients [PDF]
Caspian Journal of Internal Medicine, 2023 Background: The increase in serum phosphorus level is an independent risk factor for mortality in patients with chronic renal failure or undergoing dialysis due to end-stage renal disease.
Deniz Çekiç +2 more
doaj
Control of hyperphosphatemia beyond phosphate [PDF]
Kidney International, 2007 Hyperphosphatemia is a prevalent condition in the dialysis population and is associated with bad outcome. Block et al. present data from a post hoc analysis indicating that sevelamer, a noncalcium-containing phosphate binder, may confer a survival benefit in incident hyperphosphatemic hemodialysis patients.
openaire +3 more sources
British Journal of Clinical Pharmacology, Volume 91, Issue 4, Page 1233-1240, April 2025.Aims A 42‐year‐old male developed chronic primary hypoparathyroidism after total thyroidectomy. Conventional therapy led to recurrent nephrolithiasis and therefore rhPTH(1‐84) (parathyroid hormone [PTH]) treatment was considered. According to the dosing guideline for PTH, calcium plasma levels are adequately controlled with once‐daily administration ...
Maira Visscher +5 more
wiley +1 more source
, 2017 If chronic kidney disease (CKD) is associated with an impairment of kidney function, several uremic solutes are retained. Some of these exert toxic effects, which are called uremic toxins.
Glorieux, Griet +3 more
core +3 more sources